Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 48.83B | 48.89B | 47.58B | 45.09B | 45.09B | 49.04B |
Gross Profit | 10.44B | 10.31B | 10.15B | 8.37B | 10.45B | 14.24B |
EBITDA | 2.53B | 3.23B | 3.51B | 2.32B | 4.04B | 4.34B |
Net Income | 1.08B | 1.35B | 1.40B | 407.49M | 1.56B | 1.74B |
Balance Sheet | ||||||
Total Assets | 39.17B | 41.57B | 43.44B | 40.02B | 41.39B | 39.17B |
Cash, Cash Equivalents and Short-Term Investments | 3.63B | 4.51B | 6.08B | 2.01B | 4.88B | 3.63B |
Total Debt | 7.40B | 5.28B | 6.30B | 7.39B | 7.78B | 7.40B |
Total Liabilities | 16.89B | 15.36B | 18.36B | 16.44B | 17.98B | 16.89B |
Stockholders Equity | 22.28B | 26.21B | 25.07B | 23.58B | 23.41B | 22.28B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 8.73M | 5.62B | -1.92B | 1.86B | 2.90B |
Operating Cash Flow | 0.00 | 342.09M | 6.48B | -1.33B | 3.67B | 3.30B |
Investing Cash Flow | 0.00 | 20.86M | -891.63M | -710.11M | -2.18B | -405.74M |
Financing Cash Flow | 0.00 | -1.93B | -1.51B | -834.12M | -246.15M | -1.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥28.97B | 8.03 | 2.13% | 3.36% | 29.57% | ||
70 Neutral | ¥24.72B | 9.55 | 1.85% | 2.09% | -8.76% | ||
68 Neutral | ¥194.55B | 22.02 | 8.29% | 2.31% | 4.98% | 1.52% | |
68 Neutral | ¥30.82B | 12.53 | 1.83% | 1.56% | 40.56% | ||
65 Neutral | ¥24.14B | 38.32 | 2.00% | 0.93% | 330.63% | ||
64 Neutral | ¥23.39B | 17.53 | 1.99% | 6.08% | -22.00% | ||
62 Neutral | ¥25.09B | 18.56 | 1.20% | 2.76% | -3.44% |